Assyro AI

FDA Orange Book · active-ingredient family

Vorapaxar sulfate

Vorapaxar sulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:ZONTIVITY · NDA 204886

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
ZONTIVITYRLDKEY THERAPNDA 204886—May 08, 2014

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7304078Dec 23, 2027in 1 yr 6 mo
SubstanceProductU-1512

Vorapaxar sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo